| [1] |
中华医学会呼吸病学分会肺癌学组. 免疫检查点抑制剂相关肺炎诊治专家共识[J]. 中华结核和呼吸杂志, 2019, 42(11):820-825.
|
|
Lung Cancer Group, Chinese Thoracic Society. Expert consen-sus on prevention and treatment of checkpoint inhibitor pneu-monitis[J]. Chin J Tuberc Respir Dis, 2019, 42(11):820-825.
|
| [2] |
陈玮, 吴梦瑶, 李亚虎, 等. 晚期非小细胞肺癌免疫相关性肺炎影响因素及预后分析[J]. 中华肿瘤防治杂志, 2023, 30(20):1223-1229.
|
|
Chen W, Wu MY, Li YH, et al. Analysis of influencing factors and prognosis of immune associated pneumonia in advanced non-small cell lung cancer[J]. Chin J Cancer Prev Treat, 2023, 30(20):1223-1229.
|
| [3] |
Zhao B, Zhao H, Zhao JX. Fatal adverse events associated with programmed cell death protein 1 or programmed cell death-ligand 1 monotherapy in cancer[J]. Ther Adv Med Oncol, 2020, 12:1758835919895753.
|
| [4] |
胡银燕, 赵林芳, 贺晓映, 等. 1例食管癌术后并发重度免疫检查点抑制剂相关肺炎及吻合口瘘患者的护理[J]. 中华护理杂志, 2024, 59(14):1752-1756.
|
|
Hu YY, Zhao LF, He XY, et al. Nursing care of a postoperative patient with esophageal cancer complicated by severe immune checkpoint inhibitor-related pneumonia and anastomotic fistula[J]. Chin J Nurs, 2024, 59(14):1752-1756.
|
| [5] |
魏艳秋, 季辰菲, 孙伟, 等. 肺癌合并免疫检查点抑制剂相关肺炎的临床特征和预后分析[J]. 南京医科大学学报(自然科学版), 2024, 44(7):947-953.
|
|
Wei YQ, Ji CF, Sun W, et al. Clinical features and prognosis of immune checkpoint inhibitor-related pneumonitis in lung cancer[J]. J Nanjing Med Univ(Nat Sci), 2024, 44(7):947-953.
|
| [6] |
Ma K, Lu YL, Jiang SS, et al. The relative risk and incidence of immune checkpoint inhibitors related pneumonitis in patients with advanced cancer:a meta-analysis[J]. Front Pharma-col, 2018, 9:1430.
|
| [7] |
陈茹萱, 刘湘宁, 徐燕, 等. 非小细胞肺癌患者并发免疫检查点抑制剂肺炎的临床特征及预后分析[J]. 中华结核和呼吸杂志, 2024, 47(3):207-213.
|
|
Chen RX, Liu XN, Xu Y, et al. Clinical features and prognostic analysis of checkpoint inhibitor pneumonitis in patients with non-small cell lung cancer[J]. Chin J Tuberc Respir Dis, 2024, 47(3):207-213.
|
| [8] |
Shannon VR, Anderson R, Blidner A, et al. Multinational Asso-ciation of Supportive Care in Cancer(MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events:pulmonary toxicity[J]. Support Care Can-cer, 2020, 28(12):6145-6157.
|
| [9] |
朱文亮, 秦秉玉. 急性呼吸窘迫综合征患者的氧合目标[J]. 中国实用内科杂志, 2022, 42(6):467-471.
|
|
Zhu WL, Qin BY. Objective of oxygenation in patients with acute respiratory distress syndrome[J]. Chin J Pract Intern Med, 2022, 42(6):467-471.
|
| [10] |
中国医师协会急诊医师分会, 中华医学会急诊医学分会, 中国急诊专科医联体, 等. 急诊成人经鼻高流量氧疗临床应用专家共识[J]. 中国急救医学, 2021, 41(9):739-749.
|
|
Emergency Physicians Branch of the Chinese Medical Asso-ciation, Emergency Medicine Branch of the Chinese Medical Association, China Emergency Specialist Medical Association, et al. Expert consensus on clinical application of nasal high flow oxygen therapy for emergency adults[J]. Chin J Crit Care Med, 2021, 41(9):739-749.
|
| [11] |
王亚如, 邓银辉, 熊忱, 等. 经鼻高流量湿化氧疗流量设置对成人呼吸衰竭患者影响的研究进展[J]. 临床肺科杂志, 2024, 29(7):1116-1119,1126.
|
|
Wang YR, Deng YH, Xiong C, et al. Research progress on the influence of nasal high-flow humidification oxygen therapy flow setting on adult respiratory failure patients[J]. J Clin Pulm Med, 2024, 29(7):1116-1119,1126.
|
| [12] |
郭桂华, 许小明, 王海靓, 等. 脑卒中呼吸系统感染患者气道管理的最佳证据总结[J]. 中华护理杂志, 2023, 58(1):31-38.
DOI
URL
|
|
Guo GH, Xu XM, Wang HL, et al. Summary of the best evidence of airway nursing management in patients with respiratory infection after stroke[J]. Chin J Nurs, 2023, 58(1):31-38.
DOI
URL
|
| [13] |
刘莉, 李静, 刘小芳, 等. 住院患者高血糖的个体化目标管理[J]. 中国全科医学, 2023, 26(15):1824-1830.
DOI
|
|
Liu L, Li J, Liu XF, et al. Targets for individualized inpatient management of hyperglycemia[J]. Chin Gen Pract, 2023, 26(15):1824-1830.
|
| [14] |
石慧鑫, 蒋梦媛, 邵煜涵, 等. 耶氏肺孢子菌肺炎研究进展[J]. 中国真菌学杂志, 2024, 19(2):206-210.
|
|
Shi HX, Jiang MY, Shao YH, et al. Research progress of pneu-mocystis yersinia pneumonia[J]. Chin J Mycol, 2024, 19(2):206-210.
|